Skip to main content
Top
Published in: Obesity Surgery 6/2020

01-06-2020 | Obesity | Original Contributions

Private and Public Bariatric Surgery Trends in New Zealand 2004–2017: Demographics, Cardiovascular Comorbidity and Procedure Selection

Authors: Monica Garrett, Katrina Poppe, Andrew Wooding, Rinki Murphy

Published in: Obesity Surgery | Issue 6/2020

Login to get access

Abstract

Background

For bariatric surgery, patient selection, procedural choice and availability has changed over time internationally. We analysed the annual volume and location of bariatric surgery in New Zealand by demographic characteristics, clinical history and procedure.

Methods

Patients who underwent bariatric procedures between 1 January 2004 and 31 December 2017 were identified through New Zealand hospitalisation records. Hospitalisation and medication data were used to indicate a clinical history of cardiovascular disease (CVD) and/or diabetes. Publicly funded intervention rate by ethnicity was calculated using year- and sex-specific ethnic population estimates and obesity prevalence statistics.

Results

This study included 9109 patients, undergoing gastric bypass (GB, n = 3323) and sleeve gastrectomy (SG, n = 5452) as the most common procedures. Nationally, annual bariatric surgery volume increased in the public sector, from 34 to 516 between 2004 and 2017, with a similar increase in available private sector figures. Public recipients were significantly more likely to have a history of diabetes (33.8% vs 14.4%) and/or CVD (9.0% vs 4.7%) than private recipients. Male recipients had higher prevalence of diabetes (29.9% vs 17.6%) and CVD (12.9% vs 4.1%) than female recipients. After adjustment for the adult population prevalence of morbid obesity, Pacific people had half the intervention rate of European and Māori.

Conclusion

Bariatric surgery is increasing in frequency in New Zealand, with SG and GB being the most common procedures. Significant differences in patient characteristics exist between the public and private sectors. Ensuring equitable selection of publicly funded bariatric surgery candidates remains a challenge.
Literature
2.
go back to reference Jull A, Lawes C, Eyles H, et al. Clinical guidelines for weight management in New Zealand adults. Wellington: New Zealand Ministry of Health, Clinical Trials Research Unit; 2009. p. 102. ISBN 978-0-478-33987-1. Jull A, Lawes C, Eyles H, et al. Clinical guidelines for weight management in New Zealand adults. Wellington: New Zealand Ministry of Health, Clinical Trials Research Unit; 2009. p. 102. ISBN 978-0-478-33987-1.
3.
go back to reference Lal A, Moodie M, Ashton T, et al. Health care and lost productivity costs of overweight and obesity in New Zealand. Aust N Z J Public Health. 2012 Dec 10;36(6):550–6.CrossRef Lal A, Moodie M, Ashton T, et al. Health care and lost productivity costs of overweight and obesity in New Zealand. Aust N Z J Public Health. 2012 Dec 10;36(6):550–6.CrossRef
4.
go back to reference Mann J, Flint R, Liu A, et al. Clinical guidelines for weight management in New Zealand adults. Wellington: New Zealand Ministry of Health, Clinical Trials Research Unit; 2017. p. 42. ISBN 978-1-98-853916-4. Mann J, Flint R, Liu A, et al. Clinical guidelines for weight management in New Zealand adults. Wellington: New Zealand Ministry of Health, Clinical Trials Research Unit; 2017. p. 42. ISBN 978-1-98-853916-4.
5.
go back to reference Kelly S, Flint R. New Zealand is far behind Australia in offering weight-loss surgery. NZMJ. 2015;128(1408):10–2. Kelly S, Flint R. New Zealand is far behind Australia in offering weight-loss surgery. NZMJ. 2015;128(1408):10–2.
6.
go back to reference Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.CrossRef
7.
go back to reference Sjöström L, Narbro K, Sjöström C, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRef Sjöström L, Narbro K, Sjöström C, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.CrossRef
8.
go back to reference Reges O, Greenland P, Dicker D, et al. Association of bariatric surgery using laparoscopic banding, roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality. JAMA. 2018;319(3):279–90.CrossRef Reges O, Greenland P, Dicker D, et al. Association of bariatric surgery using laparoscopic banding, roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality. JAMA. 2018;319(3):279–90.CrossRef
9.
go back to reference Mcleod B, Beban G, Sanderson J, et al. Bariatric surgery makes dramatic difference to health-related quality of life. NZMJ. 2012;125(1363):46–52. Mcleod B, Beban G, Sanderson J, et al. Bariatric surgery makes dramatic difference to health-related quality of life. NZMJ. 2012;125(1363):46–52.
10.
go back to reference Yip S, Plank L, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994–2003.CrossRef Yip S, Plank L, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23(12):1994–2003.CrossRef
11.
go back to reference Crémieux P-Y, Ledoux S, Clerici C, et al. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg. 2010;20(7):861–70.CrossRef Crémieux P-Y, Ledoux S, Clerici C, et al. The impact of bariatric surgery on comorbidities and medication use among obese patients. Obes Surg. 2010;20(7):861–70.CrossRef
12.
go back to reference Gounder S, Wijayanayaka D, Murphy R, et al. Costs of bariatric surgery in a randomised control trial (RCT) comparing Roux en Y gastric bypass vs sleeve gastrectomy in morbidly obese diabetic patients. NZMJ. 2016;129(1443):43–52. Gounder S, Wijayanayaka D, Murphy R, et al. Costs of bariatric surgery in a randomised control trial (RCT) comparing Roux en Y gastric bypass vs sleeve gastrectomy in morbidly obese diabetic patients. NZMJ. 2016;129(1443):43–52.
13.
go back to reference Yska J, van der Meer D, Dreijer A, et al. Influence of bariatric surgery on the use of medication. Eur J Clin Pharmacol. 2015;72(2):203–9.CrossRef Yska J, van der Meer D, Dreijer A, et al. Influence of bariatric surgery on the use of medication. Eur J Clin Pharmacol. 2015;72(2):203–9.CrossRef
14.
go back to reference Vest A, Heneghan H, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.CrossRef Vest A, Heneghan H, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.CrossRef
15.
go back to reference Rahiri J-L, Lauti M, Harwood M, et al. Ethnic disparities in rates of publicly funded bariatric surgery in New Zealand (2009-2014). ANZ J Surg. 2017;88(5):6–8. Rahiri J-L, Lauti M, Harwood M, et al. Ethnic disparities in rates of publicly funded bariatric surgery in New Zealand (2009-2014). ANZ J Surg. 2017;88(5):6–8.
16.
go back to reference Wells S, Riddell T, Kerr A, et al. Cohort profile: the PREDICT cardiovascular disease cohort in New Zealand primary care (PREDICT-CVD 19). Int J Epidemiol. 2015;46(1):22–22j. Wells S, Riddell T, Kerr A, et al. Cohort profile: the PREDICT cardiovascular disease cohort in New Zealand primary care (PREDICT-CVD 19). Int J Epidemiol. 2015;46(1):22–22j.
17.
go back to reference Bartholomew K, Sharpe S, Cormack D, Hancock A, Phimmavanh M. Health Information Standards Organisation 10001:2017 ethnicity data protocols. New Zealand Ministry of Health. 2017. 37 p. ISBN 978-1-98-850291-5. Bartholomew K, Sharpe S, Cormack D, Hancock A, Phimmavanh M. Health Information Standards Organisation 10001:2017 ethnicity data protocols. New Zealand Ministry of Health. 2017. 37 p. ISBN 978-1-98-850291-5.
22.
go back to reference R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2017. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2017.
23.
go back to reference Microsoft. Microsoft Excel for Mac version 16.16.12. Microsoft, 2018. Microsoft. Microsoft Excel for Mac version 16.16.12. Microsoft, 2018.
24.
go back to reference Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89.CrossRef Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89.CrossRef
25.
go back to reference Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2009;6(1):8–15.CrossRef Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2009;6(1):8–15.CrossRef
26.
go back to reference Peterli R, Wölnerhanssen B, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.CrossRef Peterli R, Wölnerhanssen B, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.CrossRef
27.
go back to reference Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241–54.CrossRef Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241–54.CrossRef
28.
go back to reference Khorgami Z, Shoar A, Andalib A, et al. Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates. Surg Obes Relat Dis. 2017;13(5):774–8.CrossRef Khorgami Z, Shoar A, Andalib A, et al. Trends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates. Surg Obes Relat Dis. 2017;13(5):774–8.CrossRef
29.
go back to reference Sharman M, Breslin M, Kuzminov A, et al. Population estimates and characteristics of Australians potentially eligible for bariatric surgery: findings from the 2011–13 Australian Health Survey. Aust Health Rev. 2017;42(4):429–37.CrossRef Sharman M, Breslin M, Kuzminov A, et al. Population estimates and characteristics of Australians potentially eligible for bariatric surgery: findings from the 2011–13 Australian Health Survey. Aust Health Rev. 2017;42(4):429–37.CrossRef
30.
go back to reference Scuffham P, Krinks R, Chaulkidou K, et al. Recommendations from two citizens’ juries on the surgical management of obesity. Obes Surg. 2018;28(6):1745–52.CrossRef Scuffham P, Krinks R, Chaulkidou K, et al. Recommendations from two citizens’ juries on the surgical management of obesity. Obes Surg. 2018;28(6):1745–52.CrossRef
31.
go back to reference Campbell J, Venn A, Neil A, et al. Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review. Obes Rev. 2016;17(9):850–94.CrossRef Campbell J, Venn A, Neil A, et al. Diverse approaches to the health economic evaluation of bariatric surgery: a comprehensive systematic review. Obes Rev. 2016;17(9):850–94.CrossRef
32.
go back to reference Lopes E, Heineck I, Athaydes G, et al. Is bariatric surgery effective in reducing comorbidities and drug costs? A systematic review and meta-analysis. Obes Surg. 2015;25(9):1741–9.CrossRef Lopes E, Heineck I, Athaydes G, et al. Is bariatric surgery effective in reducing comorbidities and drug costs? A systematic review and meta-analysis. Obes Surg. 2015;25(9):1741–9.CrossRef
33.
go back to reference Murphy R, Ghafel M, Beban G, et al. Variation in public-funded bariatric surgery intervention rate by New Zealand region. Intern Med J. 2019;49(3):391–5.CrossRef Murphy R, Ghafel M, Beban G, et al. Variation in public-funded bariatric surgery intervention rate by New Zealand region. Intern Med J. 2019;49(3):391–5.CrossRef
Metadata
Title
Private and Public Bariatric Surgery Trends in New Zealand 2004–2017: Demographics, Cardiovascular Comorbidity and Procedure Selection
Authors
Monica Garrett
Katrina Poppe
Andrew Wooding
Rinki Murphy
Publication date
01-06-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 6/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04463-x

Other articles of this Issue 6/2020

Obesity Surgery 6/2020 Go to the issue